Product Recalls in New York

Product recalls affecting New York — including food, drugs, consumer products, medical devices, and vehicles distributed to New York. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 2,901 recalls have been distributed to New York in the last 12 months.

55,896 total recalls
2,901 in last 12 months

Showing 621640 of 13,591 recalls

DrugMarch 13, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Lacosamide Tablets Recalled by Glenmark Pharmaceuticals Inc., USA Due to...

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 13, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Pravastatin Sodium Tablets Recalled by Glenmark Pharmaceuticals Inc., USA...

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 13, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Carvedilol Tablets Recalled by Glenmark Pharmaceuticals Inc., USA Due to...

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 13, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Propafenone Hydrochloride Extended-Release Capsules USP Recalled by Glenmark...

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 13, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Rufinamide Tablets 200mg Recalled by Glenmark Pharmaceuticals Inc., USA Due...

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 13, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Pravastatin Sodium Tablets 80mg Recalled by Glenmark Pharmaceuticals Inc.,...

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 13, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Diltiazem Hydrochloride Extended-Release Capsules 12HR 120mg Recalled by...

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 13, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Lacosamide Tablets 200mg Recalled by Glenmark Pharmaceuticals Inc., USA Due...

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 13, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Fluphenazine Hydrochloride Tablets Recalled by Glenmark Pharmaceuticals...

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 13, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Propafenone Hydrochloride Extended-Release Capsules Recalled by Glenmark...

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 13, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Rosuvastatin Tablets 40mg Recalled by Glenmark Pharmaceuticals Inc., USA Due...

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 13, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Indomethacin Extended-Release Capsules Recalled by Glenmark Pharmaceuticals...

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 13, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Clindamycin Hydrochloride Capsules Recalled by Glenmark Pharmaceuticals...

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 13, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Nitroglycerin Sublingual Tablets 0.3MG Recalled by Glenmark Pharmaceuticals...

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 13, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Lacosamide Tablets Recalled by Glenmark Pharmaceuticals Inc., USA Due to...

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 13, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Propafenone Hydrochloride Extended-Release Capsules 225mg Recalled by...

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 13, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Voriconazole Tablets 200 mg Recalled by Glenmark Pharmaceuticals Inc., USA...

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 13, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Solifenacin Succinate Tablets 10MG Recalled by Glenmark Pharmaceuticals...

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 13, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Teriflunomide Tablets Recalled by Glenmark Pharmaceuticals Inc., USA Due to...

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMarch 13, 2025· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Fluphenazine Hydrochloride Tablets 2.5mg Recalled by Glenmark...

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund